We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+18.58%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$4.62B
AUM Growth
+$1.01B
Cap. Flow
+$495M
Cap. Flow %
10.7%
Top 10 Hldgs %
44.42%
Holding
475
New
42
Increased
242
Reduced
147
Closed
26

Sector Composition

Rank Sector Weight
1 Miscellaneous 63.08%
2 Technology 15.48%
3 Healthcare 5.51%
4 Financials 4.27%
5 Communication Services 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUB icon
301
iShares Short-Term National Muni Bond ETF
SUB
$11.6B
$558K 0.01%
5,243
+33
+0.6% +$3.51K
FBND icon
302
Fidelity Total Bond ETF
FBND
$28.1B
$556K 0.01%
12,218
+157
+1% +$7.16K
ED icon
303
Consolidated Edison
ED
$39B
$553K 0.01%
5,001
+148
+3% +$16.1K
NKE icon
304
Nike
NKE
$53.1B
$547K 0.01%
13,334
-95,030
-88% -$4.18M
IYE icon
305
iShares US Energy ETF
IYE
$1.85B
$543K 0.01%
9,590
-2
-0% -$121
LNG icon
306
Cheniere Energy
LNG
$55.3B
$535K 0.01%
2,240
+10
+0.4% +$2.49K
MCHP icon
307
Microchip Technology
MCHP
$37.8B
$514K 0.01%
5,636
+18
+0.3% +$1.6K
YUM icon
308
Yum! Brands
YUM
$37.6B
$514K 0.01%
3,212
+9
+0.3% +$1.39K
KRE icon
309
State Street SPDR S&P Regional Banking ETF
KRE
$4.23B
$507K 0.01%
6,776
+12
+0.2% +$840
PLTR icon
310
Palantir
PLTR
$419B
$504K 0.01%
4,319
-4,167
-49% -$568K
MET icon
311
MetLife
MET
$61.8B
$503K 0.01%
5,951
-30
-0.5% -$2.42K
MCK icon
312
McKesson
MCK
$103B
$503K 0.01%
666
-23
-3% -$18.2K
PH icon
313
Parker-Hannifin
PH
$116B
$499K 0.01%
510
-1,161
-69% -$1.06M
ESE icon
314
ESCO Technologies
ESE
$6.71B
$492K 0.01%
1,405
-14
-1% -$4.38K
QUAL icon
315
iShares MSCI USA Quality Factor ETF
QUAL
$46.3B
$487K 0.01%
2,218
+88
+4% +$18.5K
CSX icon
316
CSX Corp
CSX
$88.7B
$477K 0.01%
10,044
+287
+3% +$13K
EBC icon
317
Eastern Bankshares
EBC
$4.93B
$476K 0.01%
21,411
+102
+0.5% +$2.07K
SPHY icon
318
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12B
$472K 0.01%
20,144
-6,080
-23% -$142K
BCRX icon
319
BioCryst Pharmaceuticals
BCRX
$2.15B
$469K 0.01%
46,850
+8,898
+23% +$80.5K
ATO icon
320
Atmos Energy
ATO
$27.4B
$467K 0.01%
2,709
+8
+0.3% +$1.43K
IBRX icon
321
ImmunityBio
IBRX
$8.38B
$467K 0.01%
53,307
THG icon
322
Hanover Insurance
THG
$8.07B
$459K 0.01%
2,143
+20
+0.9% +$3.79K
CEG icon
323
Constellation Energy
CEG
$92B
$454K 0.01%
1,829
+200
+12% +$56.3K
IHE icon
324
iShares US Pharmaceuticals ETF
IHE
$1.62B
$452K 0.01%
4,567
+13
+0.3% +$1.17K
AZN icon
325
AstraZeneca
AZN
$253B
$451K 0.01%
2,381
-450
-16% -$84.6K

Similar funds

Grimes & Company's Q2 2026 Portfolio in Review

As of Q2 2026, Grimes & Company held 475 positions worth $4.62B, up 28% from $3.61B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Grimes & Company deployed $495M of net new capital in Q2 2026, opening 42 new positions and adding to 242 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 1,638,298 shares worth $158M.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 59% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $28.5M trimmed.

  • Grimes & Company's largest Q2 2026 buy was State Street SPDR Bloomberg High Yield Bond ETF: 1,638,298 shares worth $158M.
  • Grimes & Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2026, an estimated $167M increase.
  • Grimes & Company's biggest Q2 2026 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $28.5M.
  • Grimes & Company fully exited Intuit in Q2 2026, selling an estimated $8.21M.
  • Grimes & Company's ten largest holdings make up 44% of its $4.62B portfolio in Q2 2026.
  • Grimes & Company opened 42 new positions and closed 26 in Q2 2026.
  • Grimes & Company's portfolio value rose 28% quarter-over-quarter to $4.62B.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.